Is imatinib mesylate a promising drug in scleroderma due to extensive chronic graft-versus-host disease?

MeSH terms

• Benzamides
• Chronic Disease
• Female
• Graft vs Host Disease / diagnosis
• Graft vs Host Disease / drug therapy*
• Humans
• Imatinib Mesylate
• Leukemia, Lymphocytic, Chronic, B-Cell / complications
• Leukemia, Myelomonocytic, Chronic / complications
• Male
• Middle Aged
• Peripheral Blood Stem Cell Transplantation / adverse effects
• Piperazines
• Pyrimidines
• Scleroderma, Systemic / drug therapy*
• Scleroderma, Systemic / etiology
• Treatment Outcome